R R

What Is the Rejection Rate of Endothelial Corneal Transplants (DMEK/DSAEK)?

Endothelial corneal transplantation has revolutionized the treatment of corneal diseases like Fuchs' Dystrophy. Unlike traditional Penetrating Keratoplasty (PKP), which replaces the entire thickness of the cornea, endothelial keratoplasty (EK) only replaces the diseased inner layer of cells. The two primary types are DSAEK (Descemet Stripping Automated Endothelial Keratoplasty) and the newer, thinner DMEK (Descemet Membrane Endothelial Keratoplasty). Because less donor tissue is introduced and the eye's surface remains largely intact, the immunological response is significantly lower than in full-thickness procedures.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is the Rejection Rate of Endothelial Corneal Transplants (DMEK/DSAEK)?

Endothelial corneal transplantation has revolutionized the treatment of corneal diseases like Fuchs' Dystrophy. Unlike traditional Penetrating Keratoplasty (PKP), which replaces the entire thickness of the cornea, endothelial keratoplasty (EK) only replaces the diseased inner layer of cells. The two primary types are DSAEK (Descemet Stripping Automated Endothelial Keratoplasty) and the newer, thinner DMEK (Descemet Membrane Endothelial Keratoplasty). Because less donor tissue is introduced and the eye's surface remains largely intact, the immunological response is significantly lower than in full-thickness procedures.

read more about DMEK DSAEK rejection rate ...

Copy this HTML:

Copy HTML Copied!

Comparative Rejection Rates

The rejection rate for endothelial transplants is remarkably low compared to traditional methods. Clinical data in 2026 indicates that DMEK has the lowest rejection rate of any corneal transplant procedure, with approximately 1 percent to 3 percent of patients experiencing a rejection episode within the first two years. DSAEK carries a slightly higher but still favorable rejection rate of about 5 percent to 10 percent. For context, traditional full-thickness transplants (PKP) can have rejection rates as high as 15 percent to 20 percent. The thinner the graft, the less "antigenic load" is presented to the patient's immune system, which explains the superior safety profile of DMEK.

Immunology and Graft Survival Data

Graft survival refers to whether the transplanted tissue remains clear and functional over time. While rejection is an immune response that can often be reversed with steroid drops, graft failure is the permanent loss of clarity. Five-year survival data for both DMEK and DSAEK is excellent, often exceeding 90 percent in uncomplicated cases. The primary immunological advantage of EK is that it avoids the need for many surface sutures, which are known to attract blood vessels and immune cells that increase the risk of rejection in full-thickness surgery.

Risk Factors for Graft Rejection

While the overall rates are low, certain factors can increase the likelihood of a rejection episode. Patients with active ocular inflammation, previous glaucoma surgeries (such as tubes or shunts), or a history of multiple previous transplants are at a higher risk. In these cases, the "microenvironment" of the front of the eye is more prone to identifying the donor tissue as foreign. Surgeons in 2026 manage these high-risk patients with specialized long-term topical steroid regimens or immunosuppressive drops like cyclosporine to maintain the stability of the endothelial graft.

Signs of Endothelial Rejection

Early detection is the most critical factor in successfully treating a rejection episode. When the immune system attacks the new endothelial cells, they stop pumping fluid out of the cornea, leading to swelling and cloudiness. Patients are taught to monitor for the "RSVP" symptoms: Redness, Sensitivity to light, Vision decrease, and Pain. If a patient notices these signs and begins high-dose steroid treatment immediately, the vast majority of endothelial rejection episodes can be fully reversed without permanent damage to the graft.

FAQs on DMEK and DSAEK Rejection

Is rejection the same as the transplant "falling off"?

No. A transplant failing to adhere is called a "graft detachment," which is a mechanical issue usually fixed by injecting a small air or gas bubble into the eye. Rejection is an immune system attack on the cells themselves. Both are treatable, but they require different clinical approaches.

Do I have to take anti-rejection pills?

Most patients only require topical eye drops to prevent rejection. Because the eye is "immunologically privileged," systemic immunosuppression pills are rarely needed for corneal transplants unless the patient has a very high-risk history or multiple failed previous grafts.

How long am I at risk for rejection?

While the highest risk period is in the first twelve months, rejection can technically occur at any time, even years later. This is why most surgeons recommend a "maintenance dose" of a mild steroid drop once a day or a few times a week indefinitely for endothelial transplant recipients.

When to Consult Your Corneal Specialist

If you have had a DMEK or DSAEK and notice even a subtle "fog" in your vision or increased glare around lights, you should contact your surgeon for an urgent evaluation. Early intervention with steroid drops can save a graft that is beginning to reject, preventing the need for a repeat transplant. Regular follow-up appointments allow your doctor to check the health of your endothelial cells using a specialized camera called a specular microscope, ensuring the graft remains healthy and stable.

References

https://www.corneal.org/patient-resources/types-of-transplants
https://pubmed.ncbi.nlm.nih.gov/27530366/
https://www.aao.org/eye-health/treatments/dmek-corneal-transplant